After discontinuing development of its lead asset, Fulcrum Therapeutics has provided more details on its restructure, with 48 of 57 employees headed out the door. Fulcrum Therapeutics’ restructure ...

With few treatments available for sickle cell disease, encouraging early clinical data for a Fulcrum Therapeutics drug made it one to watch. But another medicine from the same drug class was recently ...

Fulcrum Therapeutics (FULC) lost nearly 50% of its value in extended trading after the company disclosed plans to discontinue the development of its lead asset, pociredir, for sickle cell disease in ...

The oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and organ damage and reduce life expectancy. Sign up here. Pociredir ...

Fulcrum has been left with no option but to abandon its ambitions for pociredir in SCD and “explore strategic alternatives.” (Photo by Sarah Silbiger/Getty Images) Fulcrum Therapeutics has scrapped ...

Fulcrum Therapeutics has begun a strategic review that may result in it getting sold, a move made after the company’s main medicine hit a possibly insurmountable obstacle. On Tuesday, Fulcrum ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

― Decision follows FDA feedback regarding the implications of the secondary malignancies observed with Tazverik ® (tazemetostat) and the product’s subsequent global withdrawal on the benefit-risk ...

At last year’s Unbound Gravel, Cameron Jones averaged a staggering 22.49mph for more than eight hours to win the men’s race and Karolina Migon won the women’s Unbound 200 with a speed of 20.21mph. In ...

Fulcrum has released two wheelsets with a 30mm internal, 36mm external rim width designed around the needs of gravel racers. The Fulcrum Sharq GR has Fulcrum’s standard cup and cone bearings and 24 ...

Mumbai, January 28, 2026 — Fulcrum, an insurtech startup founded by Indian-origin entrepreneurs Arjun Mangla and Sambhav Anand, has raised $25 million in combined Seed and Series A funding in a round ...

Fulcrum secures $25 million across Seed and Series A rounds. Funding accelerates product development and adoption among large brokerages. The platform reduces manual brokerage work with integrated AI ...